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Abstract 
Endogenous neuropeptides orexins (hypocretins) play an important role in the 
regulation of feeding, drinking, endocrine function and sleep-wakefulness. The orexin 
neuron projection sites include the rostral ventrolateral medulla of brainstem related to 
the control of breathing. Previous studies suggest that orexins modulate the central CO2 
response of ventilation during wakefulness in the rodent. These led us to examine 
effects of orexinergic system on central respiratory control by addition of orexin into the 
superfusion medium in the isolated brain stem-spinal cord of the neonatal rat in the 
present study. The application of Orexin B resulted in dose-dependent increases in C4 
burst rate via brainstem, not via spinal cord. The increases in C4 burst rate induced 
concomitant increases in the depolarizing cycle rate of preinspiratory (Pre-I) neurons 
and inspiratory (Insp) neurons. The rhythmic bursts of C4 and Pre-I neurons finally 
became to be tonic, although the rhythmic bursts of Insp neurons were maintained. 
Expiratory (Exp) neurons were also depolarized by the application of Orexin B. Our 
findings indicate that Orexin B activates central respiratory activity mainly through 
depolarizing and decreasess in membrane resistance of Pre-I neurons and Insp neurons, 
and possibly through early start of expiratry phase induced by depolarization of Exp 
neurons.  
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Highlights 
 
We analyse effects of orexin on central respiratory control using the isolated 
brainstem-spinal cord preparation of newborn rats. Orexin produces dose-dependent 
increases in C4 burst rate via brainstem. The increases in C4 respiratory activities are 
induced by orexin-induced depolarization of pre-inspiratory and inspiratory neurons.  
 
 
 
 
*Highlights (for review)
Introduction 
Endogenous neuropeptides orexins (hypocretins) play an important role in the 
regulation of feeding, drinking, endocrine function and sleep/wakefulness (Gastreau 
2008). Additionally, both anatomical and functional evidences indicate that orexins are 
related to the regulation of breathing (Corcoran 2010).  
Orexin is synthesized by neurons of the lateral hypothalamus (Sakurai 1998). These 
Orexin neurons projects to the ventrolateral medulla and phrenic nuclei of the 
respiratory network with dense fiber (Young JK 2005), indicating that orexin is possibly 
included in respiratory regulation. In fact, the intracerebroventricular injection of orexin 
induces increases in ventilation (Zhang et al. 2005). Furthermore, previous studies 
indicates that orexin-containing axonal projections innervate the spinal cord (Date 2000; 
Hervieu 2001). However, little is known as to how they work in central respiratory 
control in brainstem (Gastreau 2008) and how they modulate respiratory activities 
through the spinal cord.  
In the present study, we examined effects of orexinergic system on central respiratory 
control at the level of respiratory neurons and spinal cord by addition of orexin B into 
the superfusion medium in the isolated brain stem-spinal cord of the neonatal rat. 
*Manuscript
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Method 
All procedures were conducted in accordance with the guidelines of the institutional 
scientific committee. Data were obtained from 45 neonatal rats (0–4 days old, Wistar 
rats). 
 
Isolated brainstem–spinal cord preparation 
The isolated brainstem–spinal cord preparation has been described in detail elsewhere 
(Sakuraba et al., 2003). In brief, the rats were deeply anesthetized with diethyl ether, and 
the brainstem and cervical spinal cord segment C6 were isolated in a chamber filled with 
oxygenated artificial cerebrospinal fluid (ACSF). The cerebellum and pons were ablated. 
The preparation was transferred to a 2 ml recording chamber, and fixed, ventral side up, 
to a silicon rubber base with miniature pins. The preparation was superfused at 25-26 °C 
with control ACSF equilibrated with a control gas mixture (2% CO2 in O2; pH = 7.8) at a 
flow rate of 4ml/min. This relatively alkaline superfusate allowed the tissue pH of the 
superficial (<400 µm) medullary layer to be maintained in the physiological range 
(Okada et al., 1993). The composition of the ACSF was (in mM) 126 NaCl, 5 KCl, 1.25 
NaH2PO4, 1.5 CaCl2, 1.3 MgSO4, 26 NaHCO3 and 30 glucose. C4 ventral root activity 
was recorded using a glass suction electrode, amplified with a conventional AC amplifier 
(AVH 11, Nihon Kohden, Tokyo, Japan), and integrated (time constant: 100 ms). The 
signals were recorded on a thermal array recorder and stored on digital tape for 
subsequent analysis. 
The C4 respiratory rate and peak amplitude (Integ. C4) were measured. 
 
Neuronal recording 
The intracellular activity of inspiratory (Insp), preinspiratory (Pre-I) and expiratory (Exp) 
neurons in the superficial (<400µm) rostral ventrolateral medulla (RVLM) was recorded 
using a perforated patch clamp technique (Kuwana et al., 1998). Neurons were identified 
and classified on the basis of their firing patterns and the temporal correlation of their 
activity to the respiratory cycle of C4 ventral root activity (Onimaru et al., 1997). Insp 
neurons discharge action potentials during the inspiratory phase (C4 burst activity phase) 
(Fig. 3A). Pre-I neurons are characterized by preinspiratory and postinspiratory action 
potential discharges and hyperpolarization during the inspiratory phase (Fig. 3B). Exp 
neurons discharge action potentials between inspiratory phases, and hyperpolarize during 
the inspiratory phase. A glass pipette (GC100-TF-10, Clark, Reading, UK) was pulled 
with a horizontal puller (PA-91, Narishige, Tokyo, Japan) to a tip size of approximately 
2µm. Electrode resistance ranged from 12 to 16MΩ when the pipette was filled with a 
solution containing (in mM) 140 K-gluconate, 3 KCl, 10 EGTA, 10 HEPES, 1 CaCl2, 1 
MgCl2, and nystatin (100 µg/ml). pH was maintained at 7.2–7.3 using KOH. The 
micropipette was inserted into the RVLM using a manual hydraulic micromanipulator. 
Membrane potentials were recorded using a single-electrode voltage clamp amplifier 
(CEZ 3100, Nihon Kohden, Tokyo, Japan). Neurons were located by applying positive 
pressure (10–20 cm H2O) inside the pipette. After a gigaohm seal was obtained, the 
recorded membrane potential gradually became negative, and stabilized in about 10 min. 
The membrane potential was presented without correcting the liquid junction potential. 
The resulting perforated patch recording remained stable for more than 60 min. 
 
Protocol 
Experiment-1  
We analysed the effects of orexin B on C4 respiratory rate and Integ. C4. After the 
preparation was superfused with control ACSF (CO2 fraction 2%) for at least 30 min and 
C4 activity reached a steady state, the control superfusate was replaced by a test solution: 
a control group and three orexin B (Peptide Institute, Osaka, Japan）groups at 
concentrations 0.01, 0.1, or 1.0µM; each group contained 5 preparations. In the orexin B 
groups, after obtaining a baseline recording, the superfusate was replaced by solution 
containing orexin B at the specified concentration, and recording was resumed for 10 
min, followed by a washout period using the control ACSF for 10 min. .  
 
Experiment-2  
We used a separate perfusion system (Sakuraba et al., 2003) to distinguish the action of 
orexin B on medulla and spinal cord. The brainstem–spinal cord was separated between 
the medulla and C1 roots, and separately perfused with control ACSF and ACSF 
containing 0.1µM orexin B. Ten preparations were randomly allocated to medulla 
perfusion group or spinal cord perfusion group. Each group contained 5 preparations. 
  
Experiment-3 
We analyzed the effect of orexin B on Insp, Pre-I and Exp neurons in the medulla. After 
the control recording, control ACSF was changed to ACSF containing 0.1µM orexin B 
for 10 min, followed by a 10 min washout period using control ACSF. Intraburst firing 
frequencies and resting membrane potential of Pre-I and Exp neurons are represented by 
the mean firing frequency during the expiratory phase, and intraburst firing frequencies 
and resting membrane potential of Insp neurons are represented by the mean firing 
frequency during the inspiratory phase. 
 
Statistical analyses 
All data before and during the application of orexin B were analyzed using the paired 
t-test. A one-way ANOVA with Tukey-Kramer test was used to compare values between 
different concentration groups. P < 0.05 was considered significant. Data are expressed 
as mean ± SD.   
 
Results 
Experiment-1 
Integ. C4 burst rates were significantly increased by orexin B 0.1 µM (from 3.80 ± 0.57 
to 4.80 ± 0.58 bursts/min; 127.2% ± 13.7% of control; P < 0.05; n = 4) and orexin B 1.0 
µM (from 4.37 ± 0.47 to 5.90 ± 0.28 bursts/min; 137.3% ± 20.0% of control; P < 0.001; 
n = 6) , however, orexin B 0.01 µM did not (from 4.33 ± 0.42 to 4.25 ± 0.36 bursts/min; 
98.4% ± 8.46% of control; n = 6) (Fig.1A-C). These orexin-induced changes of Integ. 
C4 burst rates were resulted in dose-dependent manner (Fig.1D).  
And, of further interest, we found that C4 tonic discharge was induced by the 
application of orexin B 0.1 µM and 1.0 µM in all preparations (Fig.1B,C). The C4 
amplitude did not significantly change in any concentration of orexin B (Fig.1A-C).  
 
Experiment-2 
The application of Orexin B 0.1 µM to the medulla, Integ. C4 burst rate significantly 
increased (from 2.58 ± 0.99 to 4.98 ± 1.21 bursts/min; Fig.2 A; P <0.01), however, 
orexin B 0.1 µM to the spinal cord did not (from 4.04 ± 0.68 to 4.20 ± 1.20 bursts/min; 
Fig.2 B).  
On the other hand, Orexin B 0.1 µM did not induce any significant changes in the the 
C4 amplitude in both to medulla group (96.1 ± 9.99 % of control; Fig.2 A) and to spinal 
cord group (104.0 ± 16.4% of control; Fig.2 B). Interestigly, we found that C4 tonic 
discharge was induced by the application of orexin B 0.1 µM only to spinal cord, not to 
medulla.  
 
 
 Experiment-3 
We analysed the effects of orexin B 0.1 µM on 16 respiratory neurons in RVLM. We 
classified these neurons into three groups—Insp, Pre-I and Exp—based on their firing 
patterns during perfusion with control ACSF. The application of orexin B 0.1 µM 
significantly increased Integ. C4 burst rate from 5.14 ± 1.78 to 7.54 ± 1.99 (P < 0.0001; 
n = 16).  
 
3.1 Effects of NMBAs on Insp neurons and Pre-I neurons 
Orexin B 0.1 µM induced a synchronous increases in C4 respiratory rate and rhythmic 
burst rate in Insp neurons and Pre-I neurons in the early stage of orexin B effects from 
5.74 ± 1.65 to 6.98 ± 1.59 ( P < 0.05; n = 5) and from 5.12 ± 1.36 to 8.05 ± 1.66 ( P < 
0.01; n = 6). Finally, rhythmic C4 burst became to be tonic even though rhythmic burst 
of Insp neuron and Pre-I neurons were maintained in all preparations (Fig. 3A, B). Also,  
Orexin B 0.1 µM induced significant decreases in input membrane resistance and 
depolarization in Insp neurons and Pre-I neurons during orexin-induced respiratory 
acceleration (Fig. 3A, B; Table).  
 
3.2. Effects of NMBAs on Exp neurons 
In Exp neurons, input membrane resistance was slightly decreased by the application of 
Orexin B 0.1 µM, but the difference was not significant (Fig. 3C; Table; P = 0.18), 
although orexin B 0.1 µM induced significant depolarization in Exp neurons (Fig. 3C; 
Table; P < 0.0001). The rhythmic inhibitory potential cycle rate of Exp neurons was 
synchronously increased with C4 respiratory rate by the application of orexin B 0.1 µM 
(Fig. 3C).  
Disscussion 
We have demonstrated that orexin B induce dose-dependent increases in C4 respiratory 
rate in the isolated brainstem-spinal cord preparations of newborn rats, and these 
increases in C4 respiratory rate are synchronous with increases in depolarizing cycle 
rate of Pre-I neurons and Insp neurons. Orexin B activates central respiratory activity 
mainly through depolarizing and decreasess in membrane resistance of Pre-I neurons 
and Insp neurons, and possibly through early start of expiratry phase induced by 
depolarization of Exp neurons. Also, we found that orexin B induces C4 tonic discharge 
with no effects on the amplitude of C4, indicating that orexin B possibly induces direct 
effects on spinal cord.  
 
In the in vivo model, activation of orexin receptors at different levels of the brainstem 
and spinal cord elicits breathing activity differently. Although stimulation of the 
hypothalamus (Kayaba Y et al., 2003) and microinjection of orexin into pons induces 
increases in respiratory frequency (Dutschmann M et al. 2007), microinjection of orexin 
into the ventrolateral medulla including central respiratory control increases the tidal 
volume without any effects on respiratory frequency (Young JK et al. 2005; Liu ZB et al. 
2010). Contraly, in the isolated brainstem-spinal cord preparations of newborn rats, 
hypothalamus where orexin is synthesized (Sakurai T et al. 1998) and sends dense fiber 
projections to many brain regions including central respiratory control (Gestreau C et al. 
2008) and pons are ablated (Okada Y et al. 1998). Therefore, it is the most ideal model 
to analyse the pure effects of orexin on central respiratory control and phrenic activities.   
Our result that orexin induces increases in respiratory frequency without any 
effects on C4 amplitude is contradictory to the above in vivo results orexin 
microinjected into the ventrolateral medulla increases the tidal volume without any 
effects on respiratory frequency (Young JK et al. 2005; Liu ZB et al. 2010). In general,  
removal of the vagal afferent inputs (Onimaru H, 1995) induce changes in respiratory 
frequency, not amplitude, by the application of some drugs in the isolated 
brainstem-spinal cord preparations of newborn rats. On the other hand, respiratory 
stimulator increases only the amplitude of inspiratory activity without vagal feedback in 
the in vivo (Eugenin J et al. 2001). Therefore, our results in the in vitro preparation are 
consistent with the past results in the in vivo study.   
It is found that projections of orexin-containing neurons to respiratory-related 
brain stem regions and neurons of the pre-Bötzinger complex express orexin receptors 
(Young JK wt al. 2005). As mentioned above, it is also found that orexin produces 
increases in respiratory activities, although respiratory neuronal mechanisms are not 
analysed. In the present study, we could demonstrate that orexin activates central 
respiratory activity mainly through depolarizing and decreasess in membrane resistance 
of Pre-I neurons and Insp neurons, and possibly through early start of expiratry phase 
induced by depolarization of Exp neurons. Orexin possibly lowers the membrane 
resistance of these respiratory neurons by opening some channel of respiratory neurons 
and then induces depolarization of these neurons. However, further studies are needed 
to analyse these channel mechanisms.  
 
Orexin does not induce any significant changes in the C4 amplitude but C4 
tonic discharge is induced by the application of orexin only to spinal cord, indicating 
that orexin might modulate respiration-unrelated lumbar motoneurons by several 
pathways. Orexin receptors produce neuroexcitation by post-synaptic depolarization via 
activation of non-selective cation channels, inhibition of K
+
 chanels, activation of 
Na+/Ca
2+
-excahnge and Ca
2+
 influx via L-type Ca
2+
 chanel activation (Kukkonen JP 
and Leonard CS. 2013;  Wu WN et al. 2013). Also, inhibition of 
hyperpolarization-activated/cyclic nucleotide-gated chasnnels and enhancement of 
excitation of pyramidal neurons in prelimbic cortex (Li B et al. 2010) might be related 
to orexin-induced C4 tonic discharges. Further studies are needed to analyse the 
mechanisms of these orexin-induced C4 tonic discharge.     
 
In conclusion, orexin produces dose-dependent increases in C4 burst rate via brainstem, 
not via spinal cord. The increases in C4 burst rate induced concomitant increases in the 
depolarizing cycle rate of Pre-I neurons and inspiratory Insp neurons. The rhythmic 
bursts of C4 and Pre-I neurons finally became to be tonic, although the rhythmic bursts 
of Insp neurons were maintained. Exp neurons were also depolarized by the application 
of Orexin. Orexin activates central respiratory activity mainly through depolarizing and 
decreasess in membrane resistance of Pre-I neurons and Insp neurons, and possibly 
through early start of expiratry phase induced by depolarization of Exp neurons.  
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Figure legend 
 
Fig.1 Effects of orexin B on the C4 respiratory activity 
Representative sample tracing of integrated C4 activity before, during and after 
superfusion with control and orexin B solution at concentrations 0.01µM (A), 0.1µM 
(B), and 1.0µM (C). Higher concentrations of orexin B tended to produce significant 
increase in C4 burst rate in dose-dependent manner (D). *P ＜ 0.05 vs control, **P ＜ 
0.05 between different concentration groups) 
 
Fig.2 Effect of orexin B on the medulla and the spinal cord 
Representitive sample tracing of integrated C4 activity before, during and after separate 
superfusion with 0.1µM orexin B solution (A: medulla, B: spinal cord). C4 burst rate  
increases after application of orexin B 0.1µM (A). C4 tonic discharge were observed in 
all preparation of spinal cord groups (A), however, it was not observed in any 
preparation of medulla groups (B).  
 
Fig.3  
Representitive sample tracing of inspiratory neuron (A), preinspiratory neuron (B) and 
expiratory neuron (C) with integrated C4 activity before, during and after superfusion 
with 0.1µM orexin B solution.  
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Table  
 Em: resting membrane potential; Ri: input membrane resistance 
 * P < 0.05 
** P < 0.01 
*** P < 0.0001 
 
Table    
Effects of orexin B on resting membrane potential and membrane resistance of respiratory neurons 
  control 0.1µM Orexin 
Insp neurons (n = 5) 
Em (mV) -63.6 ± 18.1 -56.4 ± 17.1** 
Ri (MΩ) 484.0 ± 185.1 322.0 ± 113.2* 
Pre-I neurons (n = 6) 
Em (mV) -62.0 ± 7.7 -55.3 ± 8.0** 
Ri (MΩ) 540.0 ± 207.8 426.7 ± 206.9** 
Exp neurons (n = 5) 
Eml (mV) -55.4 ± 19.1 -48.2 ± 20.0*** 
Ri (MΩ) 640 ± 306.9 494.0 ± 251.2 
Table
